Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product Transcatheter Pulmonary Valve System
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product Transcatheter Pulmonary Valve System
Filed with SSE · Stock code 688198 · · 3 pages · Chinese
Summary by 6ix AI
Beijing Balance Medical Technology Co. Ltd. announced the approval for registration of its innovative Transcatheter Pulmonary Valve System, which aims to address the needs of patients requiring pulmonary valve replacement. The product is designed to accommodate a wide range of anatomical variations in patients, ensuring effective treatment for all-comer cases. The company emphasizes the durability and performance of the valve, which is comparable to existing surgical bioprosthetic valves, making it suitable for younger patients. The announcement also highlights the potential market impact and uncertainties regarding future sales and revenue from this product.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Beijing Balance Medical Technology Co. Ltd. on 6ix
Story so far
- Announcement on Implementation Results of Share Repurchase
- Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product, Valved Patch for Complex Congenital Heart Disease
- Announcement on Voluntary Disclosure of the Aortic Root Enlargement Patch Entering the Special Review Procedure for Innovative Medical Devices
Earlier from Beijing Balance Medical Technology
- Announcement on Implementation Results of Share Repurchase
- Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product, Valved Patch for Complex Congenital Heart Disease
- Announcement on Voluntary Disclosure of the Aortic Root Enlargement Patch Entering the Special Review Procedure for Innovative Medical Devices
- Announcement on Voluntary Disclosure of the Failure to Obtain Approval for the Registration Application for Ophthalmic Surgical Biological Patch
- Semi-annual Report for 2026
Later from Beijing Balance Medical Technology
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Vesting Results for the 4th Vesting Period of the Reserved Grant under the 2020 Restricted Share Incentive Plan and Listing of Shares
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of Entry of ePTFE Pulmonary Artery Valved Conduit into the Special Review Procedure for Innovative Medical Devices
- (688198)"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure Regarding the Entry of the Minimally Invasive Pre-positionable Sutureless Aortic Valve System into the Special Review Procedure for Innovative Medical Devices
Follow Beijing Balance Medical Technology into a list and get an email when it puts out news.
Follow Beijing Balance Medical Technology